全部资讯｜CELL INTELLIGENCE

Bimodal PET/CT and PET/MRI imaging in multiple myeloma/prostate cancer restaging and response to BCMA-targeted CAR T-therapy assessment.

PubMed 2026/03/25 发表Eur J Nucl Med Mol ImagingQ1 · IF 7.6（JCR 2025）

Cutting edge developments in bone oncology - Highlights from the Cancer and Bone Society 2024 annual meeting.

PubMed 2025/11/01 发表J Bone OncolQ2 · IF 3.6（JCR 2025）

Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cells.

PubMed 2025/04/24 发表Cancer Immunol ImmunotherQ1 · IF 5.8（JCR 2025）

研究表明，在不同肿瘤实体中，BM 存在免疫细胞组成的改变。此外，TIGIT 检查点分子以及嘌呤能通路的分子在浸润 BM 的 CD8+ T 细胞、NK 细胞和巨噬细胞中异常表达，并且对肿瘤细胞裂解也具有功能相关性。

Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report.

PubMed 2025/04/01 发表Front OncolQ2 · IF 3.4（JCR 2025）

Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors.

PubMed 2025/03/26 发表JCO Precis OncolQ2 · IF 4.7（JCR 2025）

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models.

PubMed 2025/02/20 发表Cancer CellQ1 · IF 56.1（JCR 2025）

The emerging role of targeted protein degradation to treat and study cancer.

PubMed 2024/06/17 发表J PatholQ1 · IF 5.4（JCR 2025）

全部资讯 7